Document is current

Any future updates will be listed below

Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI)

Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P384

Published Online: 2015-11-04

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark